Adoptive chemoimmunotherapy of murine leukemia: dissemination, survival, and function of helper T lymphocyte clones.
D000818:Animals; D000938:Antigen-Presenting Cells / Q000276:immunology; D000945:Antigens, Differentiation, T-Lymphocyte / Q000032:analysis; D000951:Antigens, Neoplasm / Q000276:immunology; D002470:Cell Survival; D002999:Clone Cells / Q000276:immunology; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D006968:Hypersensitivity, Delayed; D007111:Immunity, Cellular; D007116:Immunization, Passive; D007942:Leukemia, Experimental / Q000188:drug therapy / Q000628:therapy*; D008213:Lymphocyte Activation; D051379:Mice; D012191:Retroviridae Proteins / Q000276:immunology; D015682:Retroviridae Proteins, Oncogenic; D006377:T-Lymphocytes, Helper-Inducer / Q000145:classification / Q000276:immunology*; D014759:Viral Envelope Proteins / Q000276:immunology
D000945:Antigens, Differentiation, T-Lymphocyte; D000951:Antigens, Neoplasm; D012191:Retroviridae Proteins; D015682:Retroviridae Proteins, Oncogenic; D014759:Viral Envelope Proteins; D003520:Cyclophosphamide